Breaking News Instant updates and real-time market news.

ALXN

Alexion

$116.97

2.32 (2.02%)

07:49
01/22/19
01/22
07:49
01/22/19
07:49

Credit Suisse sees limited fundamental impact to Alexion from EU IP setback

Credit Suisse analyst Martin Auster notes that Alexion indicated that the European Patent Office has revoked the new Soliris formulation patent previously granted, following an opposition from potential competitors. The company expects to receive the written decision over the next few weeks, when it will likely appeal the outcome, a process that could take 3-5 years, Auster notes. The analyst believes investors currently assign limited protective value from this formulation patent, with no change to his thesis from a fundamental perspective. He reiterates an Outperform rating and $156 price target on the shares.

  • 28

    Jan

  • 04

    Feb

  • 18

    Feb

ALXN Alexion
$116.97

2.32 (2.02%)

12/21/18
RAJA
12/21/18
NO CHANGE
RAJA
Outperform
Alexion's early ultomiris approval 'arrives at perfect time,' says Raymond James
Raymond James analyst Laura Chico noted that FDA approval of Alexion's ultomiris comes nearly two full months before the PDUFA date, stating that the approval "arrives at a perfect time and facilitates a potentially earlier 2019 launch." The approval should help lift an overhang on shares, said Chico, who likes the setup for the stock for 2019 and keeps an Outperform rating on Alexion shares.
12/21/18
PIPR
12/21/18
NO CHANGE
Target $177
PIPR
Overweight
Piper says Alexion early approval should help continue complement 'dominance'
Piper Jaffray analyst Christopher Raymond notes that expectations were for Ultomiris to be approved in February, meaning today's decision came roughly two months early, which will pull forward the timeline for Alexion's market conversion from Soliris to Ultomiris. The earlier than expected approval, along with the "high bar Ultomiris has set," positions Alexion to "continue its dominance in the complement space," said Raymond. He maintains an Overweight rating and $177 price target on Alexion shares.
12/24/18
STFL
12/24/18
NO CHANGE
STFL
Hold
Alexion consensus will need to come down due to Ultimoris pricing, says Stifel
Stifel analyst Paul Matteis said Alexion's U.S. pricing for Ultomiris is below what he had modeled and it does not appear to him that sell-side numbers align with the company's conservative pricing strategy, leading him to tell investors that "Street numbers will need to come down to incorporate a new reality." However, he also sees "two major positives" from the pricing decision: namely that it should provide a "huge" tailwind for Soliris-to-Ultomiris conversions and that the company should earn "valuable brand equity" with payors. Matteis keeps a Hold rating on Alexion shares.
01/03/19
PIPR
01/03/19
NO CHANGE
PIPR
Piper sees Alexion, Biogen as potential targets after Celgene buyout
Piper Jaffray analyst Christopher Raymond remains "bullish on biotech" in the wake the announced acquisition of Celgene (CELG) by Bristol-Myers Squibb (BMY) for $74B in cash and stock, representing a 54% premium from yesterday's close. In a research note titled "Bristol for CELG - In Retrospect, it Makes Perfect Sense," Raymond says the market is likely to ask "who's next?" Among large-caps, Alexion Pharmaceuticals (ALXN) and Biogen (BIIB) would seem to make sense as potential targets, as well as BioMarin (BMRN), Raymond writes. And while any smid cap could likely be seen as a take-out candidate, Aimmune Therapeutics (AIMT), Deciphera Pharmaceuticals (DCPH) and Rigel Pharmaceuticals (RIGL) "in particular could make sense to any strategic buyer," adds the analyst.

TODAY'S FREE FLY STORIES

CUK

Carnival plc

$52.15

-3.54 (-6.36%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Hot Stocks
Carnival plc falls -6.2% »

Carnival plc is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

DWT

Britannia Bulk

$6.68

-0.46 (-6.44%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Hot Stocks
Britannia Bulk falls -6.5% »

Britannia Bulk is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$41.58

-3.26 (-7.27%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF falls -7.3% »

ProShares Trust Ultra VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRC

California Resources

$26.39

1.91 (7.80%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Hot Stocks
California Resources rises 7.2% »

California Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Apr

BBBY

Bed Bath & Beyond

$17.82

3.95 (28.48%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Options
Active trading in Bed, Bath and Beyond options as shares rally »

Active trading in Bed,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Apr

KEG

Key Energy

$4.48

0.59 (15.17%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Hot Stocks
Key Energy rises 15.7% »

Key Energy is up 15.7%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

IO

ION Geophysical

$13.84

0.25 (1.84%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Hot Stocks
ION Geophysical rises 7.7% »

ION Geophysical is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$137.77

1.13 (0.83%)

09:55
03/26/19
03/26
09:55
03/26/19
09:55
Hot Stocks
Janssen submits sBLA for daratumumab combination therapy to FDA »

Janssen Pharmaceutical of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 25

    Apr

WAB

Wabtec

$70.62

0.62 (0.89%)

09:55
03/26/19
03/26
09:55
03/26/19
09:55
Options
Wabtec put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBBY

Bed Bath & Beyond

$17.74

3.87 (27.90%)

, DO

Diamond Offshore

$10.69

0.39 (3.79%)

09:55
03/26/19
03/26
09:55
03/26/19
09:55
Options
Early notable gainers among liquid option names on March 26th »

Notable gainers among…

BBBY

Bed Bath & Beyond

$17.74

3.87 (27.90%)

DO

Diamond Offshore

$10.69

0.39 (3.79%)

VIAB

Viacom

$27.08

0.75 (2.85%)

RIG

Transocean

$9.27

0.44 (4.98%)

NVDA

Nvidia

$181.50

7.695 (4.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Apr

  • 22

    May

DWDP

DowDuPont

$53.96

0.7 (1.31%)

09:55
03/26/19
03/26
09:55
03/26/19
09:55
Conference/Events
House Science, Space & Technology to hold a hearing »

The Subcommittee on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 28

    May

09:51
03/26/19
03/26
09:51
03/26/19
09:51
Conference/Events
House Financial Services Committee to hold a markup »

The Committee holds a…

09:50
03/26/19
03/26
09:50
03/26/19
09:50
General news
U.S. Richmond Fed index preview: »

U.S. Richmond Fed index…

SQ

Square

$74.65

0.12 (0.16%)

09:49
03/26/19
03/26
09:49
03/26/19
09:49
Recommendations
Square analyst commentary  »

Opposition to Square ILC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,199.98

7.26 (0.61%)

, GOOGL

Alphabet Class A

$1,204.92

7.79 (0.65%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Periodicals
Google's Local Experiments Project looks to bolster community news, Axios says »

Google (GOOG, GOOGL) is…

GOOG

Alphabet

$1,199.98

7.26 (0.61%)

GOOGL

Alphabet Class A

$1,204.92

7.79 (0.65%)

MNI

McClatchy

$5.01

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$41.92

-2.92 (-6.51%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF falls -6.5% »

ProShares Trust Ultra VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWT

Britannia Bulk

$6.70

-0.44 (-6.16%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
Britannia Bulk falls -6.4% »

Britannia Bulk is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUK

Carnival plc

$51.67

-4.02 (-7.22%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
Carnival plc falls -6.6% »

Carnival plc is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

BBW

Build-A-Bear

$5.86

0.22 (3.90%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
Build-A-Bear rises 4.1% »

Build-A-Bear is up 4.1%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UCO

Universal Compression

$21.55

0.86 (4.16%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
Universal Compression rises 4.2% »

Universal Compression is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRC

California Resources

$25.64

1.16 (4.74%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
California Resources rises 4.6% »

California Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Apr

09:45
03/26/19
03/26
09:45
03/26/19
09:45
General news
U.S. consumer confidence preview: »

U.S. consumer confidence…

09:45
03/26/19
03/26
09:45
03/26/19
09:45
General news
Consumer Confidence to be reported at 10:00 »

March Consumer Confidence…

09:45
03/26/19
03/26
09:45
03/26/19
09:45
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

March Richmond Fed…

MDSO

Medidata

$75.89

(0.00%)

09:44
03/26/19
03/26
09:44
03/26/19
09:44
Hot Stocks
Breaking Hot Stocks news story on Medidata »

Medidata mentioned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.